T1	Condition 0 13	Renal disease
T2	Negation 14 23	unrelated
T3	Condition 27 30	SLE
R1	Has_negation Arg1:T3 Arg2:T2	
R2	AND Arg1:T1 Arg2:T3	
T4	Condition 37 54	diabetes mellitus
T5	Condition 76 102	tubulointerstitial disease
T6	Condition 62 72;95 102	glomerular disease
T7	Condition 104 124	renovascular disease
*	OR T4 T6 T5 T7
T8	Scope 37 124	diabetes mellitus, other glomerular or tubulointerstitial disease, renovascular disease
T9	Procedure 130 149	transplanted kidney
*	OR T1 T9
R3	Subsumes Arg1:T1 Arg2:T8	
T10	Measurement 152 188	Estimated glomerular filtration rate
T11	Measurement 190 194	eGFR
T12	Value 204 226	=20 mL/min per 1.73 m2
T13	Measurement 230 246	serum creatinine
T14	Value 247 262	>300 micromol/L
T15	Value 264 274	3.39 mg/dL
R4	Subsumes Arg1:T14 Arg2:T15	
R5	Has_value Arg1:T13 Arg2:T14	
R6	Subsumes Arg1:T10 Arg2:T11	
R7	Has_value Arg1:T10 Arg2:T12	
*	OR T10 T13
T16	Procedure 291 303	Renal biopsy
T17	Condition 324 346	fibrocellular crescent
T18	Condition 312 320;338 346	cellular crescent
*	OR T17 T18
T19	Multiplier 350 376	more than 25% of glomeruli
T20	Scope 313 346	ellular or fibrocellular crescent
R8	Has_multiplier Arg1:T20 Arg2:T19	
R9	Has_scope Arg1:T16 Arg2:T20	
T21	Qualifier 379 382	CNS
T22	Condition 422 427	lupus
T23	Qualifier 399 418	organ manifestation
T24	Procedure 456 481	immunosuppressive therapy
R10	AND Arg1:T22 Arg2:T24	
*	OR T23 T21
T25	Scope 379 418	CNS or other severe organ manifestation
R11	Has_scope Arg1:T22 Arg2:T25	
T26	Drug 523 545	corticosteroid therapy
T27	Condition 552 558	asthma
T28	Condition 560 586	inflammatory bowel disease
T29	Condition 495 509	Co-morbidities
R12	AND Arg1:T29 Arg2:T26	
*	OR T27 T28
T30	Scope 552 586	asthma, inflammatory bowel disease
R13	Subsumes Arg1:T29 Arg2:T30	
T31	Drug 605 617	prednisolone
T32	Drug 622 632	prednisone
T33	Drug 622 632;637 647	prednisone equivalent
*	OR T32 T33 T31
T34	Multiplier 652 677	>20 mg/D for over 4 weeks
T35	Temporal 689 702	past 3 months
T36	Scope 605 648	prednisolone (or prednisone, or equivalent)
R14	Has_multiplier Arg1:T36 Arg2:T34	
R15	Has_temporal Arg1:T36 Arg2:T35	
T37	Drug 720 723	MMF
T38	Multiplier 727 752	>1.5 g/D for over 4 weeks
R16	Has_multiplier Arg1:T37 Arg2:T38	
T39	Temporal 764 777	past 3 months
R17	Has_temporal Arg1:T37 Arg2:T39	
T40	Condition 786 802	hypersensitivity
T41	Condition 806 820	intolerability
T42	Drug 824 836	prednisolone
T43	Drug 841 851	prednisone
T44	Drug 841 851;856 866	prednisone equivalent
T45	Drug 869 872	TAC
T46	Drug 877 880	MMF
T47	Multiplier 894 917	1.25 g or below per day
R18	Has_multiplier Arg1:T46 Arg2:T47	
*	OR T40 T41
T48	Scope 786 820	hypersensitivity or intolerability
*	OR T42 T43 T44 T45 T46
T49	Scope 824 917	prednisolone (or prednisone, or equivalent), TAC, or MMF at a dose of 1.25 g or below per day
R19	Has_scope Arg1:T48 Arg2:T49	
T50	Drug 963 966	TAC
T51	Drug 968 980	cyclosporine
T52	Drug 994 1015	calcineurin inhibitor
T53	Multiplier 1020 1032	over 4 weeks
T54	Temporal 1044 1059	past 12 months.
*	OR T50 T51 T52
T55	Scope 963 1015	TAC, cyclosporine or any other calcineurin inhibitor
R20	Has_multiplier Arg1:T55 Arg2:T53	
R21	Has_temporal Arg1:T55 Arg2:T54	
T56	Drug 1076 1092	cyclophosphamide
T57	Drug 1094 1105	leflunomide
T58	Drug 1110 1122	methotrexate
T59	Multiplier 1132 1139	2 weeks
*	OR T56 T57 T58
T60	Procedure 1151 1167	biological agent
T61	Temporal 1206 1219	past 6 months
T62	Scope 1076 1122	cyclophosphamide, leflunomide, or methotrexate
R22	Has_multiplier Arg1:T62 Arg2:T59	
*	OR T62 T60
T63	Scope 1076 1170	cyclophosphamide, leflunomide, or methotrexate for over 2 weeks, or use of biological agent(s)
R23	Has_temporal Arg1:T63 Arg2:T61	
T64	Negation 1316 1323	allowed
T65	Drug 1240 1252	azathioprine
T66	Drug 1254 1264	mizoribine
T67	Drug 1278 1293	immunoglobulins
T68	Drug 1298 1312	anti-malarials
*	OR T68 T67 T66 T65
T69	Scope 1240 1312	azathioprine, mizoribine, intravenous immunoglobulins and anti-malarials
R24	Has_negation Arg1:T69 Arg2:T64	
T70	Condition 1340 1352	hypertension
T71	Qualifier 1327 1339	Uncontrolled
R25	Has_qualifier Arg1:T70 Arg2:T71	
T72	Measurement 1358 1369	systolic BP
T73	Measurement 1383 1395	diastolic BP
T74	Value 1370 1379	>160 mmHg
T75	Value 1396 1404	>95 mmHg
*	OR T72 T73
R26	Has_value Arg1:T72 Arg2:T74	
R27	Has_value Arg1:T73 Arg2:T75	
T76	Scope 1358 1404	systolic BP >160 mmHg or diastolic BP >95 mmHg
R28	Subsumes Arg1:T70 Arg2:T76	
T77	Pregnancy_considerations 1407 1446	Women who are pregnant or breastfeeding
T78	Pregnancy_considerations 1449 1558	Women with childbearing potential or their male partners, who refuse to use an effective birth control method
